Viewing nowRipigrel Extended-Release Tablet 300 mg (Sarpogrelate Hydrochloride)
Sarpogrelate Hydrochloride 200mg
Tablet · Prescription medication
Korea Union Pharmaceutical Co., Ltd.

MFDS item code 201903483 · Approved 2019.05.28 · Insurance code 665507440
Improvement of ischemic symptoms (ulcers, pain, etc.) in chronic arterial occlusion
This medication improves ischemic symptoms such as ulcers, pain, and cold sensation due to chronic arterial occlusion. It is used for vascular occlusive diseases such as Buerger's disease, obliterative arteriosclerosis, and diabetic peripheral vascular disease to facilitate blood circulation and alleviate symptoms. This drug helps reduce pain through improved blood flow, promotes the recovery of tissue damage, and enhances the quality of life. It is effectively used for improving these ischemic symptoms.
Orally administer 300 mg of Sarpogrelate Hydrochloride extended-release tablet once daily after meals. This medication should be taken whole without chewing or breaking.
This medication should not be used in patients with bleeding as it may increase the risk of bleeding. It is advisable for women who are pregnant or may become pregnant to avoid taking this medication. Women who are menstruating or have a tendency to bleed should use this medication cautiously. Patients taking anticoagulants or antiplatelet drugs are at increased risk of bleeding and should exercise caution. Patients with severely impaired kidney function or elderly patients require special attention when using this medication. During treatment with this drug, various side effects such as rash, dyspepsia, diarrhea, headache, cough, and changes in blood pressure may occur, so any abnormal symptoms should be reported immediately. Additionally, symptoms of bleeding, anemia, liver dysfunction, and allergic reactions may occur, hence regular blood tests and medical supervision are necessary. When taken with anticoagulants, the risk of bleeding may further increase, so caution is advised when co-administered. It is recommended that women who are pregnant or breastfeeding do not take this medication, and if necessary, breastfeeding should be discontinued. Safety in pediatric patients has not been established, and since there is no experience with its use, it is advisable not to administer this medication to children. This medication must be kept out of reach of children, and transferring it to another container can adversely affect quality, so caution is needed.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. It is advisable to maintain the storage temperature between 1 to 30 degrees Celsius at room temperature. Proper storage will help ensure the medication's effectiveness.
White oblong film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSarpogrelate Hydrochloride 200mg
Tablet · Prescription medication
Korea Union Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Yuhan Corporation

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Korea United Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
(Co., Ltd.) Pharmgen Science

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Dongkook Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Haewon Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Allico Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.